AI Model Rivals Troponin Test in Heart Attack Diagnosis

Researchers develop an Artificial Intelligence model that effectively predicts the need for urgent heart attack treatment, matching high-sensitivity testing accuracy.

An artificial intelligence model trained to detect blocked coronary arteries using electrocardiogram (ECG) readings has been shown to perform on par with high-sensitivity troponin T testing. According to research presented at the American College of Cardiology’s Annual Scientific Session, the AI model was able to identify which patients required urgent treatment for heart attacks with significant accuracy.

Unlike other AI tools focused on high-risk populations, this open-source model was designed for broader application across general emergency department populations. It demonstrated particular efficacy in diagnosing non-ST elevation myocardial infarction (NSTEMI) heart attacks, which typically challenge clinicians due to their subtle ECG changes. The model’s ability to improve prediction speed for urgent coronary revascularization could reduce treatment delays.

The research involved training on data from roughly 145,000 emergency visits and validating it on 35,000 further cases, both internally and across a German center. The model outperformed clinician ECG interpretation and conventional troponin testing, showing potential to complement clinical diagnostics by providing earlier alerts and triggering confirmatory testing. Future studies are being planned to assess its practical application and benefits in a clinical setting.

69

Impact Score

Compression and voice models reshape Artificial Intelligence efficiency

Recent releases focused on infrastructure rather than headline model breakthroughs, with gains in compression and voice systems pointing to lower inference costs and broader deployment. Google and Mistral highlighted two distinct paths for real-time audio, while TurboQuant targeted one of the most expensive bottlenecks in long-context inference.

Judge blocks Pentagon move against Anthropic

A federal judge temporarily blocked the Pentagon from labeling Anthropic a supply chain risk after finding major gaps between public threats, legal authority, and the government’s courtroom arguments. The dispute has become a test of how far the government can go in punishing an Artificial Intelligence company over political and contractual conflict.

Anumana wins FDA clearance for pulmonary hypertension ECG Artificial Intelligence tool

Anumana has received FDA 510(k) clearance for an Artificial Intelligence-enabled pulmonary hypertension algorithm designed for use with standard 12-lead electrocardiograms. The company says the software can help clinicians spot early signs of disease within existing workflows and without moving patient data outside the health system environment.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.